Global burden of MDR-TB and XDR-TB attributable to high fasting plasma glucose from 1990 to 2019: a retrospective analysis based on the global burden of disease study 2019.

Yuqian ChenJin LiuQianqian ZhangHuan ChenLimin ChaiYan WangJia ZhangYuanjie QiuNirui ShenXiangyu ShiQingting WangJian WangShaojun LiManxiang Li

Published in: European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology (2024)

The burden of HFPG-attributable MDR-TB and XDR-TB rose worldwide from 1990 to 2019. These findings emphasize the importance of routine bi-directional screening and integrated management for drug-resistant TB and diabetes.

Keyphrases

drug resistant
multidrug resistant
mycobacterium tuberculosis
acinetobacter baumannii
type diabetes
blood glucose
risk factors
insulin resistance
metabolic syndrome
adipose tissue
weight loss
clinical practice